Press Release

Seven Bridges is supporting Pfizer in the development of a data management and collaboration solution for the biopharmaceutical company's single-cell ribonucleic acid (RNA) sequencing...

Resolve Biosciences, the pioneer in Molecular Cartography™, today announced initial results from several prominent early access collaborations with leading laboratories across Europe. Teams of scientists are...

Molecular Stethoscope Inc, a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/NASH patients with clinically...

OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical Center (UPMC) to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting immunotherapy combinations for patients in a Phase II clinical ...

Rapid reporting at high throughput enables detection of potential vaccine escaping variant strains Zymo Research announced today their COVID-19 Variant Sequencing Service. This new global service expands Zymo Research’s end-to-end SARS-CoV-2 solutions that include sample collection, RNA extraction, and SARS-CoV-2 detection. Detecting ...

Kioxia Corporation is pleased to announce its contribution to the acceleration of large-volume data analysis in the research outcomes described in a new paper “Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems”, published in the journal Science(1). This ...

Neuried, Germany – 19 January 2021 – Life Science Newswire – The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties.Most of the approximately ...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2...

Bayer and Veracyte today announced a new collaboration to advance the Precision Oncology Patient Identification Program in thyroid cancer. Through the program, Bayer will offer testing with...

Mogrify Limited a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, today announced it had secured the assignment of...